ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,587Gold OA

Lipids in Health and Disease

Abbreviation (ISO):LIPIDS HEALTH DIS
•
Identifier (ISSN):1476-511X(Print)
•
Publisher:BioMed Central
Clarivate IF (2026)
6.9↑ +2.7
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Lipids in Health and Disease

WoS Q1
14692.6620182.6520192.9120203.8820214.3220224.520233.920244.220256.92026
Annual Impact Factor Metric
Current (2026):6.9
Scopus SJR & RankScopus Q1
1.448
#2,587

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
113

113 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
172articles/year
100% Gold OA•88.89% Original Research

Aims & Scope

Lipids in Health and Disease is an open access, peer-reviewed, journal that publishes articles on all aspects of lipids: their biochemistry, pharmacology, toxicology, role in health and disease, and the synthesis of new lipid compounds. Lipids in Health and Disease is aimed at all scientists, health professionals and physicians interested in the area of lipids. Lipids are defined here in their broadest sense, to include: cholesterol, essential fatty acids, saturated fatty acids, phospholipids, inositol lipids, second messenger lipids, enzymes and synthetic machinery that is involved in the metabolism of various lipids in the cells and tissues, and also various aspects of lipid transport, etc. In addition, the journal also publishes research that investigates and defines the role of lipids in various physiological processes, pathology and disease. In particular, the journal aims to bridge the gap between the bench and the clinic by publishing articles that are particularly relevant to human diseases and the role of lipids in the management of various diseases.

Topics Covered (Recognized by AI)
Biology98.9%Medicine97.6%Internal medicine96%Chemistry94.2%Biochemistry93.5%Endocrinology90.5%Pathology67%Organic chemistry66.9%Cholesterol63%Fatty acid53.7%Genetics52.8%Clinical chemistry50%Lipidology44.6%Diabetes mellitus37.3%Clinical nutrition29.8%Obesity27.9%Gene27.6%Physics24.9%Mathematics22.4%Disease21.8%Statistics21%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank49/328
IndexSCIE
JCRSCIE2026

NUTRITION & DIETETICS

Q1
Rank15/114
IndexSCIE
JCISCIE2026

BIOCHEMISTRY & MOLECULAR BIOLOGY

Q1
Rank52/328
IndexSCIE
JCISCIE2026

NUTRITION & DIETETICS

Q1
Rank14/114
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.9
Articles / Year215
Total Citations97
2025
IF4.2
Articles / Year428
Total Citations2,463
2024
IF3.9
Articles / Year426
Total Citations5,947
2023
IF4.5
Articles / Year222
Total Citations3,706
2022
IF4.315
Articles / Year151
Total Citations2,908

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,587Scopus Q1SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine
Scopus Citation Rank (SJR)Q1
1.448

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.34

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,417 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,768
3-Year Documents772
Citable Documents769

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Biochemistry (medical)Q1
Clinical BiochemistryQ1
EndocrinologyQ1
Endocrinology, Diabetes and MetabolismQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区BIOCHEMISTRY & MOLECULAR BIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Lipids in Health and Disease (abbr: LIPIDS HEALTH DIS, ISSN: 1476-511X) is a peer-reviewed international scholarly journal in the field of Biology, published by BioMed Central in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 6.90, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.448 (Q1), an H-index of 113.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 172 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,417 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
BioMed Central
Publication Language
English
Frequency
Monthly
Founding Year
2002
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 85265be5-b34e-4f63-8746-9bd09733a0d9
Database Updated: 2026-10-01